Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma

Epidemiological studies support a link between cumulative sun exposure and cutaneous squamous cell carcinoma (SCC) development. However, the presumed effects of extended ultraviolet light B (UVB) exposure on tumorigenesis in the sexes have not been formally investigated. We examined differences in u...

Full description

Saved in:
Bibliographic Details
Main Authors: Erin M. Burns, Kathleen L. Tober, Judith A. Riggenbach, Donna F. Kusewitt, Gregory S. Young, Tatiana M. Oberyszyn
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Skin Cancer
Online Access:http://dx.doi.org/10.1155/2013/246848
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556628242595840
author Erin M. Burns
Kathleen L. Tober
Judith A. Riggenbach
Donna F. Kusewitt
Gregory S. Young
Tatiana M. Oberyszyn
author_facet Erin M. Burns
Kathleen L. Tober
Judith A. Riggenbach
Donna F. Kusewitt
Gregory S. Young
Tatiana M. Oberyszyn
author_sort Erin M. Burns
collection DOAJ
description Epidemiological studies support a link between cumulative sun exposure and cutaneous squamous cell carcinoma (SCC) development. However, the presumed effects of extended ultraviolet light B (UVB) exposure on tumorigenesis in the sexes have not been formally investigated. We examined differences in ultimate tumorigenesis at 25 weeks in mice exposed to UVB for either 10 or 25 weeks. Additionally, we investigated the effect of continued UVB exposure on the efficacy of topical treatment with anti-inflammatory (diclofenac) or antioxidant (C E Ferulic or vitamin E) compounds on modulating tumorigenesis. Vehicle-treated mice in the 25-week UVB exposure model exhibited an increased tumor burden and a higher percentage of malignant tumors compared to mice in the 10-week exposure model, which correlated with increases in total and mutant p53-positive epidermal cells. Only topical diclofenac decreased tumor number and burden in both sexes regardless of UVB exposure length. These data support the commonly assumed but not previously demonstrated fact that increased cumulative UVB exposure increases the risk of UVB-induced SCC development and can also affect therapeutic efficacies. Our study suggests that cessation of UVB exposure by at-risk patients may decrease tumor development and that topical NSAIDs such as diclofenac may be chemopreventive.
format Article
id doaj-art-a94cdae7023748cba2cf5c9b06b370ab
institution Kabale University
issn 2090-2905
2090-2913
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Skin Cancer
spelling doaj-art-a94cdae7023748cba2cf5c9b06b370ab2025-02-03T05:44:56ZengWileyJournal of Skin Cancer2090-29052090-29132013-01-01201310.1155/2013/246848246848Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell CarcinomaErin M. Burns0Kathleen L. Tober1Judith A. Riggenbach2Donna F. Kusewitt3Gregory S. Young4Tatiana M. Oberyszyn5Department of Pathology, The Ohio State University, 1645 Neil Avenue, 129 Hamilton Hall, Columbus, OH 43210, USADepartment of Pathology, The Ohio State University, 1645 Neil Avenue, 129 Hamilton Hall, Columbus, OH 43210, USADepartment of Pathology, The Ohio State University, 1645 Neil Avenue, 129 Hamilton Hall, Columbus, OH 43210, USADepartment of Molecular Carcinogenesis, Science Park, UT MD Anderson Cancer Center, 1808 Park Road 1C, Smithville, TX 78957, USACenter for Biostatistics, The Ohio State University, 2012 Kenny Road, Columbus, OH 43221, USADepartment of Pathology, The Ohio State University, 1645 Neil Avenue, 129 Hamilton Hall, Columbus, OH 43210, USAEpidemiological studies support a link between cumulative sun exposure and cutaneous squamous cell carcinoma (SCC) development. However, the presumed effects of extended ultraviolet light B (UVB) exposure on tumorigenesis in the sexes have not been formally investigated. We examined differences in ultimate tumorigenesis at 25 weeks in mice exposed to UVB for either 10 or 25 weeks. Additionally, we investigated the effect of continued UVB exposure on the efficacy of topical treatment with anti-inflammatory (diclofenac) or antioxidant (C E Ferulic or vitamin E) compounds on modulating tumorigenesis. Vehicle-treated mice in the 25-week UVB exposure model exhibited an increased tumor burden and a higher percentage of malignant tumors compared to mice in the 10-week exposure model, which correlated with increases in total and mutant p53-positive epidermal cells. Only topical diclofenac decreased tumor number and burden in both sexes regardless of UVB exposure length. These data support the commonly assumed but not previously demonstrated fact that increased cumulative UVB exposure increases the risk of UVB-induced SCC development and can also affect therapeutic efficacies. Our study suggests that cessation of UVB exposure by at-risk patients may decrease tumor development and that topical NSAIDs such as diclofenac may be chemopreventive.http://dx.doi.org/10.1155/2013/246848
spellingShingle Erin M. Burns
Kathleen L. Tober
Judith A. Riggenbach
Donna F. Kusewitt
Gregory S. Young
Tatiana M. Oberyszyn
Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma
Journal of Skin Cancer
title Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma
title_full Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma
title_fullStr Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma
title_full_unstemmed Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma
title_short Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma
title_sort extended uvb exposures alter tumorigenesis and treatment efficacy in a murine model of cutaneous squamous cell carcinoma
url http://dx.doi.org/10.1155/2013/246848
work_keys_str_mv AT erinmburns extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma
AT kathleenltober extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma
AT judithariggenbach extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma
AT donnafkusewitt extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma
AT gregorysyoung extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma
AT tatianamoberyszyn extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma